Clene Inc. (NASDAQ: CLNN)
$4.8800
+0.1600 ( +3.39% ) 24.8K
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Market Data
Open
$4.8800
Previous close
$4.7200
Volume
24.8K
Market cap
$38.22M
Day range
$4.5450 - $5.2990
52 week range
$3.8181 - $11.0000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
8-k | 8K-related | 16 | May 30, 2024 |